Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Middle Region) Peptide

SPG20 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN984337

Quick Overview for Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Middle Region) Peptide (ABIN984337)

Target

SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    ASWVSWGLVK GAEITGKAIQ KGASKLRERI QPEEKPVEVS PAVTKGLYIA

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-SPG20 Antibody(ARP55162_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

    Background

    This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome).

    Alias Symbols: KIAA0610, SPARTIN, TAHCCP1

    Protein Interaction Partner: EPS15,SMURF2,TUBA1A,ZFYVE9,ITCH,TUBA1A

    Protein Size: 666

    Molecular Weight

    73 kDa

    Gene ID

    23111

    NCBI Accession

    NM_015087, NP_055902

    UniProt

    Q8N0X7
You are here:
Chat with us!